SEC Comment Letter for Merck & Co., Inc. (MRK) (CIK 0000310158) (MRK) — Apr 9, 2008
Merck & Co., Inc. (MRK) (CIK 0000310158)
Date: April 9, 2008 · CIK: 0000310158 · Accession: 0000000000-08-018647
AI Filing Summary & Sentiment
File numbers found in text: 001-06571
Show Raw Text
Via Facsimile and U.S. Mail Mail Stop 6010 March 26, 2008 Mr. Steven Koehler Vice President and Controller Schering-Plough Corporation 2000 Galloping Hill Road Kenilworth, NJ 07033 Re: Schering-Plough Corporation Form 10-K for the Year Ended December 31, 2007 Filed February 29, 2008 File No. 001-06571 Dear Mr. Koehler: We have reviewed your filing and have the following comments. We have limited our review to only your financia l statements and related disclosures and do not intend to expand our review to other portions of your documents. In our comments, we ask you to provide us with information to better unde rstand your disclosure. Where a comment requests you to revise disclosure, the info rmation you provide should show us what the revised disclosure will look like and identify the annual or quarterly filing, as applicable, in which you intend to first include it. If you do not believe that revised disclosure is necessary, explain the reason in your response. After reviewing the information provided, we may raise additional comments and/or request that you amend your filing. Please understand that the purpose of our re view process is to assist you in your compliance with the applicable disclosure requirements and to enhance the overall disclosure in your filing. We look forward to working with you in these respects. We welcome any questions you may have about our comments or on any other aspect of our review. Feel free to call us at the telephone numbers listed at the end of this letter. Mr. Steven Koehler Schering-Plough Corporation March 26, 2008 Page 2 Item7. Management’s Discussion and Anal ysis of Financial Condition…, page 31 Liquidity and Financial Resources, page 43 Contractual Obligations and Off-Ba lance Sheet Arrangements, page 48 1. Since interest obligations re lating to long-term debt appe ar to represent material future obligations, please revise the tabl e here to include the future interest payments on this debt. Also provide us with your analysis related to the applicability of the inclusion of the divi dends that you pay related to the preferred shares. In addition, quantify in your footnote two the a ggregate potential milestone payments that have been excl uded from the table and the events that would trigger these payments. Refe r to Financial Reporting Release 72. Market Risk Disclosure, page 58 Foreign Currency Exchange Risk, page 58 2. Please revise to quantify the foreign curre ncy risk in one of the three required formats. Refer to Item 3- 05(a)(1) of Regulation S-X. Item 8. Financial statements and Supplementary Data, page 60 Notes to Consolidated Financial Statements, page 65 2. Acquisition, page 69 3. Please revise to quantify the acquired pa tents and trademarks by product type in order to better allow an investor to unde rstand the connection between these rights and the revenues that are generated from the acquired business. 18. Segment Information, page 100 Long-Lived Assets by Geographic Location, page 103 4. Please revise to exclude intangible assets from the table presented here. Refer to question 22 in the FASB Implementation Guide to FAS 131. Mr. Steven Koehler Schering-Plough Corporation March 26, 2008 Page 3 Merck/Schering-Plough Cholesterol, Partnershi p Combined Financial Statements, page 117 Notes to Combined Financial statements, page 128 2. Summary of Significant Accounting Policies, page 131 Concentration of Credit Risk, page 132 5. Please revise to quantify the net sales ma de to each of the three major customers referenced in this note to the extent th ey exceed 10% of your net revenue, instead of quantifying it on an aggregate basis. Refer to paragraph 39 of SFAS 131. * * * * Please respond to these comments within 10 business days or tell us when you will provide us with a response. Please furnish a letter that keys your responses to our comments and provides the requested information. Detailed letters greatly facilitate our review. Please furnish your letter on EDGAR under the form type label CORRESP. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes all in formation required under the Securities Exchange Act of 1934 and th at they have provided all information investors require for an informed invest ment decision. Since the company and its management are in possession of all facts re lating to a company’s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made. In connection with responding to our co mments, please provide, in your letter, a statement from the company acknowledging that: • the company is responsible for the adequacy and accuracy of the disclosure in the filing; • staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and • the company may not assert staff comme nts as a defense in any proceeding initiated by the Commission or any person under the federal secu rities laws of the United States. In addition, please be advise d that the Division of Enfo rcement has access to all information you provide to the staff of the Divi sion of Corporation Fi nance in our review of your filing or in response to our comment on your filing. Mr. Steven Koehler Schering-Plough Corporation March 26, 2008 Page 4 You may contact Kei Ino, Staff Accountan t, at (202) 551-3659 or Jim Atkinson, Accounting Branch Chief, at (202) 551- 3674 if you have questions regarding the comments. In this regard, do not hes itate to contact me, at (202) 551-3679. Sincerely, Jim B. Rosenberg Senior Assistant Chief Accountant